| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |